{
    "organizations": [],
    "uuid": "edc41c6a3e9a3dadf78821696832fd125cba94f6",
    "author": "",
    "url": "https://www.reuters.com/article/vertex-pharms-study/vertex-pharmas-quarterly-profit-falls-15-1-percent-idUSL3N1S37HE",
    "ord_in_thread": 0,
    "title": "Vertex Pharma's quarterly profit falls 15.1 percent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "(Corrects to say revenue fell, not rose, in paragraph 3)\nApril 26 (Reuters) - Vertex Pharmaceuticals Incâ€™s quarterly profit fell 15.1 percent, hurt by higher research and development spending.\nVertex said on Thursday income attributable to the company fell to $210.3 million or 81 cents per share in the three months ended March 31, from $247.8 million or 99 cents per share, a year earlier.\nVertex, one of the top U.S. manufacturers of treatments for lung disorder cystic fibrosis, said its revenue fell to $640.8 million from $714.7 million.\nThe company also separately said it had begun a late-stage study of a triple combination treatment for cystic fibrosis. (Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)\n ",
    "published": "2018-04-26T23:13:00.000+03:00",
    "crawled": "2018-04-26T23:34:41.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "corrects",
        "say",
        "revenue",
        "fell",
        "rose",
        "paragraph",
        "april",
        "reuters",
        "vertex",
        "pharmaceutical",
        "inc",
        "quarterly",
        "profit",
        "fell",
        "percent",
        "hurt",
        "higher",
        "research",
        "development",
        "spending",
        "vertex",
        "said",
        "thursday",
        "income",
        "attributable",
        "company",
        "fell",
        "million",
        "cent",
        "per",
        "share",
        "three",
        "month",
        "ended",
        "march",
        "million",
        "cent",
        "per",
        "share",
        "year",
        "earlier",
        "vertex",
        "one",
        "top",
        "manufacturer",
        "treatment",
        "lung",
        "disorder",
        "cystic",
        "fibrosis",
        "said",
        "revenue",
        "fell",
        "million",
        "million",
        "company",
        "also",
        "separately",
        "said",
        "begun",
        "study",
        "triple",
        "combination",
        "treatment",
        "cystic",
        "fibrosis",
        "reporting",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "sai",
        "sachin",
        "ravikumar"
    ]
}